NCT00463320View on ClinicalTrials.gov

A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

March 31, 2007

Study Completion Date

August 31, 2007

Conditions
Macular DegenerationAge-related Macular Degeneration
Interventions
DRUG

Pazopanib eye drops and Allergen Refresh Plus eye drops

Trial Locations (2)

58104

GSK Investigational Site, Fargo

78744

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY